Marquet RL - Search Results

1

Hepatocellular carcinoma and liver transplantation: an animal model.

Schotman SN, Schraa EO, Marquet RL, Zondervan PE, Ijzermans JN. Schotman SN, et al. Among authors: marquet rl. Transpl Int. 1998;11 Suppl 1:S201-5. doi: 10.1007/s001470050461. Transpl Int. 1998. PMID: 9664979

2

Tumor recurrence in liver grafts: two animal models.

Schotman SN, van Ijken MG, Marquet RL, Zondervan PE, IJzermans JN. Schotman SN, et al. Among authors: marquet rl. Transplant Proc. 1998 Jun;30(4):1052-3. doi: 10.1016/s0041-1345(98)00148-1. Transplant Proc. 1998. PMID: 9636426 No abstract available.

3

Late graft dysfunction after prolonged cold ischemia of the donor kidney: inhibition by cyclosporine.

Kouwenhoven EA, de Bruin RW, Heemann UW, Marquet RL, Ijzermans JN. Kouwenhoven EA, et al. Among authors: marquet rl. Transplantation. 1999 Oct 15;68(7):1004-10. doi: 10.1097/00007890-199910150-00018. Transplantation. 1999. PMID: 10532542

4

Heart valve dysfunction resulting from cellular rejection in a novel heterotopic transplantation rat model.

Oei FB, Welters MJ, Vaessen LM, Marquet RL, Zondervan PE, Weimar W, Bogers AJ. Oei FB, et al. Among authors: marquet rl. Transpl Int. 2000;13 Suppl 1:S528-31. doi: 10.1007/s001470050395. Transpl Int. 2000. PMID: 11112066

5

Transplantation of a single kidney per se does not lead to late graft dysfunction.

Kouwenhoven EA, de Bruin RW, Heemann UW, Marquet RL, IJzermans JN. Kouwenhoven EA, et al. Among authors: marquet rl. Transpl Int. 2001;14(1):38-43. doi: 10.1007/s001470050740. Transpl Int. 2001. PMID: 11263554

6

No functional benefit for hDAF-transgenic rat livers despite protection from tissue damage following perfusion with human serum.

Stockmann H, Verbakel C, Okkema P, Bonthuis F, Menoret S, Anegon I, Marquet R, IJzermans J. Stockmann H, et al. Transpl Int. 2002 Dec;15(12):595-601. doi: 10.1007/s00147-002-0463-4. Epub 2002 Oct 19. Transpl Int. 2002. PMID: 12478405

7

Prolonged survival of guinea pig hearts in rats after combined antibody and complement depletion.

Scheringa M, Blanker R, Bemelman M, Schraa E, de Bruin R, Bouwman E, IJzermans J, Marquet R. Scheringa M, et al. Transplant Proc. 1995 Feb;27(1):303-4. Transplant Proc. 1995. PMID: 7879011 No abstract available.

8

Modulation of the immune response by interferon gamma administration in a rat cardiac allograft model.

Bouwman E, IJzermans JN, vd Meide PH, Schellekens H, de Bruin RW, Marquet RL, Jeekel J. Bouwman E, et al. Among authors: marquet rl. Transplant Proc. 1989 Feb;21(1 Pt 1):465-6. Transplant Proc. 1989. PMID: 2495612 No abstract available.

9

Increase of major histocompatibility complex class II--positive cells in cardiac allografts by interferon-gamma has no impact on graft survival.

Ijzermans JN, Bouwman E, van der Meide PH, Jeekel J, Marquet RL. Ijzermans JN, et al. Among authors: marquet rl. Transplantation. 1989 Dec;48(6):1039-41. doi: 10.1097/00007890-198912000-00029. Transplantation. 1989. PMID: 2512699

10

Class II antigen expression on vascular endothelium of the graft in rat heart transplantation.

Bouwman E, IJzermans JN, Heineman E, de Bruin RW, Marquet RL, Jeekel J. Bouwman E, et al. Among authors: marquet rl. Transplant Proc. 1987 Feb;19(1 Pt 1):198-9. Transplant Proc. 1987. PMID: 3152687 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

254 results

Search Page

Filters